Defective cGAS/STING signaling not only reduced the production of type I IFN for antitumor immunity but also inhibited STING-mediated cell death [12–15, 37], resulting in a poor response to radiotherapy in patients with advanced CRC. This evidence concerns the gene CGAS and colorectal carcinoma.